Advancing Glaucoma Care: Proactive Strategies and Sustained Drug Delivery Innovations

home / case-based-roundtable-series / advancing-glaucoma-care-proactive-strategies-and-sustained-drug-delivery-innovations

Sahar Bedrood, MD, PhD, discusses how glaucoma treatment has evolved from a reactive wait-and-see approach to a more proactive strategy that emphasizes early procedural interventions such as sustained-release implants and minimally invasive surgeries to minimize medication burden and vision loss.

© 2025 MJH Life Sciences

All rights reserved.